Open AccessDual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention
Author(s) -
Qiang Wang,
Yang Kang
Publication year - 2021
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000025546
Subject(s) - medicine , vitamin k antagonist , aspirin , percutaneous coronary intervention , p2y12 , adverse effect , diabetes mellitus , relative risk , randomized controlled trial , myocardial infarction , atrial fibrillation , gastroenterology , clopidogrel , confidence interval , endocrinology , warfarin